Status:
COMPLETED
The Correlations of FeNO, Blood Eosinophils and Lung Function in Well-controlled Asthma
Lead Sponsor:
Hat Yai Medical Education Center
Conditions:
Asthma
Eligibility:
All Genders
15-80 years
Brief Summary
In Asthma, the levels of exhaled FeNO is correlated to sputum eosinophils particularly in the patient with poor controlled asthma or severe asthma. Moreover, the blood eosinophils had been studied tha...
Detailed Description
This is a single prospective trial. Enrollment will continue until 50 patients with well controlled asthma have been entered into this trial and have completed blood tests and spirometry. In this tria...
Eligibility Criteria
Inclusion
- Patients with diagnosis of asthma (according to the guidelines)
- Age \>15 years
- Patients with treating with step 3 base on GINA by only low dose ICS/LABA without oral bronchodilator with being in well controlled asthma based on ACT (\> = 23) and ACQ-7 (\<0.75) for at least 12 weeks
- Ability to provide informed consent and do spirometry following ATS guideline
Exclusion
- Pulmonary infection or exacerbation within the last 12 weeks before enrolment
- Patients with preceding taken systemic steroid 12 week before enrolment
- Additional pulmonary diseases (pneumonia, lung cancer, tuberculosis, interstitial lung disease)
- A history of smoking \>= 10 pack-year
Key Trial Info
Start Date :
August 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2020
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT04454385
Start Date
August 1 2020
End Date
October 31 2020
Last Update
January 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Narongwit Nakwan
Hat Yai, Changwat Songkhla, Thailand, 90110